Research and Development said it has fully galvanised resources and stakeholders to enable it play a pivotal role in the continental initiative.
The Institute also leveraged on its reputation as the first African Institute to develop a world class phytomedicine from drug discovery up to phase 2 clinical trials, to begin work on repurposing Niprimune, its flagship immunomodulatory agent for relevant clinical studies for COVID-19.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: